Insider · CIK 0001867310
Adrienne Farid
Files at IPSC (Century Therapeutics, Inc.). First filing Feb 7, 2024, latest Jun 11, 2025.
In brief
Adrienne Farid files SEC Form 4 as COO at IPSC (Century Therapeutics, Inc.). Since Feb 7, 2024, Adrienne Farid has reported 0 open-market buys worth $0 and 8 open-market sells worth $292k, the latest filed on Jun 11, 2025.
A track record needs three past buys with six months of prices behind them; Adrienne Farid has 0, so none is measured yet.
The newest scored trade: sold $343 of IPSC on Jun 9, 2025, filed Jun 11, 2025, scored 35 (weak).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
IPSC: Century Therapeutics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 35Weak | Century Therapeutics, Inc. | $343 552 shares | -0% | +61% from low-64% from high | |
| 35Weak | Century Therapeutics, Inc. | $563 1,024 shares | -0% | +44% from low-67% from high | |
| 35Weak | Century Therapeutics, Inc. | $1,451 2,359 shares | -2% | - | |
| 28Weak | Century Therapeutics, Inc. | $822 1,054 shares | -1% | - | |
| 28Weak | Century Therapeutics, Inc. | $1,267 1,033 shares | -1% | - | |
| 8Weak | Century Therapeutics, Inc. | $270k 53,515 shares | -37% | +291% from low-2% from high | |
| 0Weak | Century Therapeutics, Inc. | $2,358 485 shares | -0% | +267% from low-8% from high | |
| 28Weak | Century Therapeutics, Inc. | $16k 3,819 shares | -3% | +216% from low-21% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Jun 9, 2025 | IPSC Century Therapeutics, Inc. | 552 0.00% of outstanding | $343 | Jun 9, 2025 | $2,014 |
| May 5, 2025 | IPSC Century Therapeutics, Inc. | 1,024 0.00% of outstanding | $563 | May 5, 2025 | $1,451 |
| Mar 10, 2025 | IPSC Century Therapeutics, Inc. | 2,359 0.00% of outstanding | $1,451 | Mar 10, 2025 | $823 |
| Feb 3, 2025 | IPSC Century Therapeutics, Inc. | 1,054 0.00% of outstanding | $823 | Feb 3, 2025 | $1,268 |
| Nov 4, 2024 | IPSC Century Therapeutics, Inc. | 1,033 0.00% of outstanding | $1,268 | Nov 4, 2024 | $1,960 |
| Mar 7, 2024 | IPSC Century Therapeutics, Inc. | 22,831 0.04% of outstanding | $117k | Mar 7, 2024 | $171k |
| Mar 6, 2024 | IPSC Century Therapeutics, Inc. | 30,684 0.05% of outstanding | $152k | Mar 6, 2024 | $18k |
| Feb 16, 2024 | IPSC Century Therapeutics, Inc. | 485 0.00% of outstanding | $2,358 | Feb 16, 2024 | $16k |
| Feb 6, 2024 | IPSC Century Therapeutics, Inc. | 1,784 0.00% of outstanding | $8,005 | Feb 6, 2024 | $7,816 |
| Feb 5, 2024 | IPSC Century Therapeutics, Inc. | 2,035 0.00% of outstanding | $7,816 | Feb 5, 2024 | none |
Transactions
Every row this insider has filed, 20 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 9, 2025 | IPSC Century Therapeutics, Inc. | SOpen-market sale Common Stock | -552 | $0.62 | $343 | 250,141 | Jun 11, 2025 |
| May 5, 2025 | IPSC Century Therapeutics, Inc. | SOpen-market sale Common Stock | -1,024 | $0.55 | $563 | 250,693 | May 7, 2025 |
| Mar 10, 2025 | IPSC Century Therapeutics, Inc. | SOpen-market sale Common Stock | -2,359 | $0.62 | $1,451 | 131,717 | Mar 12, 2025 |
| Mar 11, 2025 | IPSC Century Therapeutics, Inc. | AGrant or award Common Stock | +120,000 | $0.00 | $0 | 251,717 | Mar 12, 2025 |
| Mar 11, 2025 | IPSC Century Therapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +120,000 | $0.00 | $0 | 120,000 | Mar 12, 2025 |
| Feb 3, 2025 | IPSC Century Therapeutics, Inc. | SOpen-market sale Common Stock | -1,054 | $0.78 | $822 | 134,076 | Feb 5, 2025 |
| Nov 4, 2024 | IPSC Century Therapeutics, Inc. | SOpen-market sale Common Stock | -1,033 | $1.23 | $1,267 | 135,130 | Nov 5, 2024 |
| Mar 7, 2024 | IPSC Century Therapeutics, Inc. | AGrant or award Common Stock | +24,000 | $0.00 | $0 | 138,149 | Mar 11, 2024 |
| Mar 7, 2024 | IPSC Century Therapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +146,000 | $0.00 | $0 | 146,000 | Mar 11, 2024 |
| Mar 6, 2024 | IPSC Century Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +30,684 | $1.03 | $32k | 144,833 | Mar 8, 2024 |
| Mar 6, 2024 | IPSC Century Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -30,684 | $4.96 | $152k | 114,149 | Mar 8, 2024 |
| Mar 7, 2024 | IPSC Century Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +22,831 | $1.03 | $24k | 136,980 | Mar 8, 2024 |
| Mar 7, 2024 | IPSC Century Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -22,831 | $5.14 | $117k | 114,149 | Mar 8, 2024 |
| Mar 6, 2024 | IPSC Century Therapeutics, Inc. | MOption exercise Stock Option (right to buy)derivative10b5-1 | -30,684 | $0.00 | $0 | 191,486 | Mar 8, 2024 |
| Mar 7, 2024 | IPSC Century Therapeutics, Inc. | MOption exercise Stock Option (right to buy)derivative10b5-1 | -22,831 | $0.00 | $0 | 168,655 | Mar 8, 2024 |
| Feb 16, 2024 | IPSC Century Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +485 | $1.03 | $500 | 114,634 | Feb 21, 2024 |
| Feb 16, 2024 | IPSC Century Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -485 | $4.86 | $2,358 | 114,149 | Feb 21, 2024 |
| Feb 16, 2024 | IPSC Century Therapeutics, Inc. | MOption exercise Stock Option (right to buy)derivative10b5-1 | -485 | $0.00 | $0 | 222,170 | Feb 21, 2024 |
| Feb 5, 2024 | IPSC Century Therapeutics, Inc. | SOpen-market sale Common Stock | -2,035 | $3.84 | $7,816 | 115,933 | Feb 7, 2024 |
| Feb 6, 2024 | IPSC Century Therapeutics, Inc. | SOpen-market sale Common Stock | -1,784 | $4.49 | $8,005 | 114,149 | Feb 7, 2024 |
Questions about Adrienne Farid
Answered from the filings on this page, as of the latest one.
Is Adrienne Farid buying or selling?
Not in the last 12 months. Adrienne Farid's latest open-market trade on SEC Form 4 was sold $343 of IPSC on Jun 9, 2025.
How did Adrienne Farid's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Adrienne Farid has 0.
Where does Adrienne Farid file Form 4?
Adrienne Farid has filed Form 4 at IPSC (Century Therapeutics, Inc.) as Chief Operations Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.